Dr Allibert obtained his Ph.D. in Molecular Biology from the University of Grenoble (France) in 1986. He has over 30 years of experience in product development, manufacturing and commercialization with major biomedical industries in the USA, Europe, and Canada. Patrice started working at bioMérieux (France) where he launched the first HLA-DR test based on molecular methods for bone marrow and graft transplantation. He then held multiple management positions in diagnostics and R&D, has acted as an expert for the European Community and as a member of the Institute Advisory Board of the CHIR Institute of Infection and Immunity. He joined GenePOC Inc. in 2012 as CEO.